It is in accordance to literature reports that some GCB-DLBCL relied on activated NF-κB, which indicated that chronic active BCR signaling mechanisms might involve in the pathogenesis of these patients [23, 24]. The gene discussed is NFKB1; the disease is diffuse large B-cell lymphoma.